Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant. - Wikidata - awgldk - TriplyDB

Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant.

Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant.

http://www.wikidata.org/entity/Q35853304

about

An Insight Into the Immunologic Events and Risk Assessment in Renal Transplantation Regulatory T Cells in Kidney Transplantation: New Directions?MicroRNAs in Kidney Transplantation: Living up to Their Expectations?The use of novel diagnostics to individualize immunosuppression following transplantation MicroRNAs, Major Players in B Cells Homeostasis and Function Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes MicroRNAs as biomarkers in solid organ transplantation Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients.Differential expression and functions of microRNAs in liver transplantation and potential use as non-invasive biomarkers.Human autophagy gene ATG16L1 is post-transcriptionally regulated by MIR142-3p Biomarkers in renal transplantation: An updated review.The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection.MiR-152 may silence translation of CaMK II and induce spontaneous immune tolerance in mouse liver transplantation.Expression profiling analysis of the microRNA response of Cynoglossus semilaevis to Vibrio anguillarum and other stimuli.A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft.Emergent Transcriptomic Technologies and Their Role in the Discovery of Biomarkers of Liver Transplant Tolerance.Tolerance signatures in transplant recipients Exosomal miR-142-3p is increased during cardiac allograft rejection and augments vascular permeability through down-regulation of endothelial RAB11FIP2 expression.Association of Serum MiR-142-3p and MiR-101-3p Levels with Acute Cellular Rejection after Heart Transplantation The regulation and function of microRNAs in kidney diseases.Liver microRNA Profile of Induced Allograft Tolerance.Circulating Organ-Specific MicroRNAs Serve as Biomarkers in Organ-Specific Diseases: Implications for Organ Allo- and Xeno-Transplantation Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment?Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study.Achieving operational tolerance in transplantation: how can lessons from the clinic inform research directions?Current status of allograft tolerance in intestinal transplantation.Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients.MicroRNAs in kidney transplantation.Genomic and proteomic fingerprints of acute rejection in peripheral blood and urine Translational implications of endothelial cell dysfunction in association with chronic allograft rejection.microRNA and Kidney Transplantation.MicroRNA-142 is a multifaceted regulator in organogenesis, homeostasis, and disease.Immune monitoring in renal transplantation: The search for biomarkers.Differential expression of circulating miR-21, miR-142-3p and miR-155 in renal transplant recipients with impaired graft function.Differential profile of activated regulatory T cell subsets and microRNAs in tolerant liver transplant recipients.The Potential of MicroRNAs as Novel Biomarkers for Transplant Rejection.Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.Operational tolerance in kidney transplantation and associated biomarkers.Immune monitoring as prerequisite for transplantation tolerance trials.

P2860

Q26747765-5C4878BD-BA8C-4BF9-BA08-78248FF8B68F Q26800184-D48140EB-E059-450D-8439-358CB2B81A95 Q26824076-E1D8E9B4-AE92-483C-BED7-54B49CA7E4A1 Q26864686-ECFE4CBF-2622-4A0F-BD2C-3EAC6640C3D6 Q27010231-9C673C42-1BBD-43F5-A128-1B0890A69F84 Q28080994-21971A99-F42D-4EB4-A586-FB6EC3550A65 Q30414748-41F09B75-7C31-4512-A598-73CC0F1FEED2 Q33574118-B8C83FBF-9B75-4B7D-B742-331AC4B4FE3D Q33649970-E261B8FF-C4F3-4620-8215-14AA5C17A77D Q33831324-CC31E3B8-6D14-4B7C-99E7-38FD2F58C382 Q33842783-FF36EBC5-3CEA-4573-A36A-CE5E5D650351 Q34489123-2B9C881E-EB3B-4A08-89A2-C4C637B6BFD5 Q34663943-9A203F13-CE62-434F-9D3F-2E86480F5B67 Q35227026-DE76138C-C40A-49E1-9E50-023C38A8F142 Q35567767-CD4FACB4-CE66-40D1-A67B-6C2A2BBBE884 Q35584849-DCBD1712-2B2A-49D0-817D-52DF27694492 Q35765609-DB4C2E1E-C7C6-4F62-A4BF-0EA6273A73FE Q35915308-90FF9D27-3823-4313-B4EE-DE3FE8ED60B2 Q36245914-8B1E32D9-908B-4546-BCEF-7049B88545A9 Q36261525-2776A9FB-56E8-46E2-8593-639552616A20 Q36960910-ACD5286D-98FC-43FC-89F9-9704E482F83F Q36976979-99EA55AA-E440-4704-B999-3CE89E06401F Q37209930-6AAB46FB-B4C0-47F9-BB0D-3FD60A093AE7 Q37462039-F8C8C19E-81C9-40A3-9B83-1E075EC55A93 Q37715369-2F7E42B9-D6EA-4FA1-86FB-1367EB9FB57E Q38091722-CDA74E2E-1D46-4C40-B616-B87930EA4E6C Q38170420-4AEAB979-BC10-4C3E-8180-6923E4734FA5 Q38187177-BCE91FEB-7EF9-47D3-8A15-DA81C90F17F9 Q38244516-D4B0BC87-A42C-4E4A-9211-53DB6AAAFD3F Q38301373-B86AF6E4-7AF8-45A9-8EB5-B1EFCF3FA5FE Q38436456-D48855DE-B8B5-488B-92C2-5599468FE98B Q38668263-42D66CF9-AEE9-47C5-B278-1A39166D238F Q38791157-B1DA0D41-F80F-441F-9D3F-37AC580DD382 Q38793766-022A7CD9-295E-4DC0-9EEC-483BD8B4CDDE Q38813338-464D2E6F-ED8D-498B-AE54-D6F18D95F469 Q39071843-E24E2A24-3F01-43E4-AA90-31CCDC903D31 Q39132986-E7B8EFCF-13E4-447A-A8AA-5FC4137EF19C Q39227299-48426935-62A3-4BCD-A1BA-81A447841810 Q39267147-78EAC59E-E210-4EAA-85AD-43F13BF513B1 Q39314792-C2AC0925-5E15-42CD-959C-7D7B7EF3784F

P2860

Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant.

http://www.wikidata.org/entity/Q35853304

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Upregulation of miR-142-3p in ...... ients with a renal transplant.

@ast

Upregulation of miR-142-3p in ...... ients with a renal transplant.

@en

type

label

Upregulation of miR-142-3p in ...... ients with a renal transplant.

@ast

Upregulation of miR-142-3p in ...... ients with a renal transplant.

@en

prefLabel

Upregulation of miR-142-3p in ...... ients with a renal transplant.

@ast

Upregulation of miR-142-3p in ...... ients with a renal transplant.

@en

P1433

Q35853304-DB3E0D71-5EE3-4998-B0EE-67E186BC02F6

P1476

Q35853304-A573FD44-1D49-4937-92A8-A48AF988357B

P2093

Q35853304-08A92860-A4F1-42CD-8686-11EAD2DB4C33

Q35853304-23B65FEE-919F-4CF0-8748-CCDC4C89623E

Q35853304-364A87A8-AB16-4E2C-9E9A-11F4262B28CA

Q35853304-97E0C007-BB6A-4C0A-A18F-9A1A3C2C1F0F

Q35853304-9DFAF9EB-6E7E-4ED6-BF53-B60FFA09A33C

Q35853304-BAD98BA4-0A51-4D32-BEAD-6A5A310C62F2

Q35853304-D33378E3-F482-4B4D-BFED-3AD0600E3E92

Q35853304-D9CD6345-AEAD-4804-8A35-90E8E0EBB1C4

P2860

Q35853304-0D36473E-D9A7-4240-A81A-8CD5E2495EBB

Q35853304-0F687727-25D1-4E24-A38E-BC3120DF44C4

Q35853304-18D04539-4D21-48AB-B131-5344854D3CB5

Q35853304-1B8A206D-195F-4677-A8E9-7770C467B6A2

Q35853304-21B6F685-85AB-4D55-9CFC-69114084BB3C

Q35853304-2346BDE0-AAE4-4E09-A93D-ADC6FD864608

Q35853304-25D8B1A9-6A39-4F4E-966C-014DCF55BFB8

Q35853304-325111B7-62A9-44A9-B522-F5844940CEB4

Q35853304-32979CBE-8DAE-45B6-B255-02BAFFB14E32

Q35853304-33417D95-BCB2-4867-B726-8645CB7637FA

P304

Q35853304-3244570C-CC69-411B-8929-B25242BBFCAE

P31

Q35853304-7E955CC2-8576-4F02-A6FE-A90B368530F8

P356

Q35853304-D639E6FC-F18E-4A29-A1A5-176FF2EFC678

P433

Q35853304-16BA3974-3538-4BA8-B852-C8D5EEB30950

P478

Q35853304-4D89C21C-B97C-4408-8937-56F723703F06

P50

Q35853304-93392029-52E4-436A-9E4B-9B72551F8D9D

P577

Q35853304-C28B18FC-3021-43D1-9ED5-68C616342F15

P698

Q35853304-30021AE3-2291-4CBB-80F8-3173B80DCF42

P932

Q35853304-A00BB79C-5D54-4C80-8773-16DE37DDB466

P356

P1433

Journal of the American Society of Nephrology

P1476

Upregulation of miR-142-3p in ...... ients with a renal transplant.

@en

P2093

Alberto Sanchez-Fueyo

http://www.w3.org/2001/XMLSchema#string

Annaïck Pallier

http://www.w3.org/2001/XMLSchema#string

Juan José Lozano

http://www.w3.org/2001/XMLSchema#string

Magali Giral

http://www.w3.org/2001/XMLSchema#string

Marc Martínez-Llordella

http://www.w3.org/2001/XMLSchema#string

Nicolas Degauque

http://www.w3.org/2001/XMLSchema#string

Richard Danger

http://www.w3.org/2001/XMLSchema#string

Sophie Brouard

http://www.w3.org/2001/XMLSchema#string

P2860

miRNAs in human cancer

A mammalian microRNA expression atlas based on small RNA library sequencing

The impact of microRNAs on protein output

miRecords: an integrated resource for microRNA-target interactions

GoMiner: a resource for biological interpretation of genomic and proteomic data

The prognostic and functional role of microRNAs in acute myeloid leukemia

Mammalian microRNAs predominantly act to decrease target mRNA levels

MicroRNAs modulate hematopoietic lineage differentiation

E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer

BANK negatively regulates Akt activation and subsequent B cell responses

P304

597-606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2011060543

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Paul Soulillou

P577

2012-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22282590

http://www.w3.org/2001/XMLSchema#string

P932

3312506

http://www.w3.org/2001/XMLSchema#string